Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

IONS

Ранг среди акций #2545
Founded in 1989 and headquartered in Carlsbad, California, Ionis... Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adult patients; and WAYLIVRA, which addresses familial chylomicronemia syndrome and familial partial lipodystrophy. Ionis also maintains a robust pipeline, with several drug candidates currently in Phase 3 clinical trials. These include Eplontersen, a monthly self-administered subcutaneous injection designed for all forms of TTR amyloidosis; Olezarsen, intended for individuals with severe hypertriglyceridemia (SHTG); Donidalorsen, for patients suffering from hereditary angioedema; ION363, aimed at amyotrophic lateral sclerosis (ALS); Pelacarsen, developed for those with established cardiovascular disease and elevated lipoprotein(a); and Tofersen, which works by inhibiting the production of superoxide dismutase 1. Beyond these late-stage assets, the company is actively researching treatments for metabolic, infectious, renal, and ophthalmic diseases, as well as various types of cancer. The firm engages in significant collaborations, notably a strategic partnership with Biogen Inc. Additionally, it holds licensing and collaboration agreements with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc.
Цена акции
$44.62
Последняя синхронизация: 2026-10-21
Рыночная капитализация
$7.41B
Изменение (1 день)
-1.73%
Изменение (1 год)
-37.60%
Страна
US
Торговля Ionis Pharmaceuticals, Inc. (IONS)

Категория

Healthcare
История цены акций Ionis Pharmaceuticals, Inc. (IONS)
Наивысшая цена закрытия: $43.87 2026-10-01

Наименьшая цена закрытия: $9.35 1991-05-01
История цены акций Ionis Pharmaceuticals, Inc. с 1991 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -12.44%
2025 118.12%
2024 -26.68%
2023 30.56%
2022 26.76%
2021 -42.71%
2020 -15.83%
2019 18.26%
2018 1.41%
2017 8.18%
2016 -17.46%
2015 0.07%
2014 49.87%
2013 299.73%
2012 39.38%
2011 -29.73%
2010 -5.16%
2009 -14.30%
2008 -25.93%
2007 41.58%
2006 123.48%
2005 -11.84%
2004 1.13%
2003 -15.98%
2002 -68.29%
2001 125.06%
2000 -2.89%
1999 -13.03%
1998 -10.89%
1997 -28.15%
1996 42.62%
1995 203.93%
1994 -36.55%
1993 -34.00%
1992 -20.56%
1991 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$527.18 23.62%
US
$251.29 835.90%
US
$137.83 -3.78%
AU
$890.85 9.42%
NL
$763.55 8.53%
CH